Skip to content

Ultrasound Guided - Incisionless Threaded Carpal Tunnel Release

Ultrasound Guided - Incisionless Thread Carpal Tunnel Release Versus Standard Mini-Open Carpal Tunnel Release for the Treatment of Carpal Tunnel Syndrome: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04101955
Enrollment
12
Registered
2019-09-24
Start date
2020-07-01
Completion date
2025-08-01
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Brief summary

The overarching long-term goal is to develop a CTS Treatment Center within the Hand Clinic that offers a variety of established and emerging treatment options in a multidisciplinary program. The ultra-minimally invasive carpal tunnel release would be one component of the program. Furthering the knowledge with regard to ultra-minimally invasive carpal tunnel release outcomes would facilitate the Hand Clinics ability to offer this procedure as a component of individualized care in the CTS Treatment Center to facilitate delivery of the appropriate level of care to the right patient.

Interventions

PROCEDUREIncisionless Threaded Carpal Tunnel

ultra-minimally invasive thread carpal tunnel release

PROCEDUREStandard Mini-Open Carpal Tunnel

open surgical carpal tunnel release

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* A diagnosis of CTS with symptoms including pain, paresthesia's, and weakness of the hand in the median nerve distribution for minimum of 3 months * Age 18-65 years old * Persistence of symptoms after 6 weeks of conservative treatment such as splinting, activity modification, and/or injection therapy. * Electromyographic evidence of mild, moderate, moderately severe, or severe median nerve neuropathy at the wrist * Ability to complete all follow up appointments

Exclusion criteria

* Previous CTS surgical release on affected side * Diabetes mellitus * Hypothyroidism * Hand arthritis (rheumatologic or osteoarthritis) * Pregnancy * Electromyographic evidence of any condition other than CTS affecting the hand * Workman's compensation * Participants not willing to make follow-up visits

Design outcomes

Primary

MeasureTime frameDescription
Change in Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) functional scoreTime Frame: Change from Baseline to 12 monthsMeasured on a symptom severity scale from 1 to 5, where 1 is normal and 5 is very serious/continued/difficult
Visual analog pain scaleTime Frame: Change from Baseline to 12 monthsPain that participant is currently experiencing the in the hand or risk(0-100)
Strength testing of gripTime Frame: Change from Baseline to 12 monthsUse dynameters
Disability of the Arm Shoulder Hand DASHTime Frame: Change from Baseline to 12 monthsThe disabilities of the arm, shoulder and hand (DASH) questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The DASH consists mainly of a 30-item disability/symptom scale, scored 0 (no disability) to 100. The main purpose of this study was to assess the longitudinal construct validity of the DASH among patients undergoing surgery. The second purpose was to quantify self-rated treatment effectiveness after surgery.
Strength testing of pinchTime Frame: Change from Baseline to 12 monthsUse pinch meters

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026